Handelsbanken Fonder
NVCR icon

Handelsbanken Fonder’s NovoCure NVCR Stock Holding History

Handelsbanken Fonder’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$776K Buy
51,223
+13,900
+37% +$210K ﹤0.01% 1240
2026
Q1 		$407K Hold
37,323
– – ﹤0.01% 1353
2025
Q4 		$483K Buy
37,323
+4,700
+14% +$60.3K ﹤0.01% 1316
2025
Q3 		$421K Hold
32,623
– – ﹤0.01% 1330
2025
Q2 		$581K Sell
32,623
-4,900
-13% -$85.4K ﹤0.01% 1185
2025
Q1 		$669K Hold
37,523
– – ﹤0.01% 1126
2024
Q4 		$1.12M Buy
37,523
+3,300
+10% +$69.8K ﹤0.01% 921
2024
Q3 		$535K Buy
34,223
+5,000
+17% +$90.7K ﹤0.01% 1214
2024
Q2 		$501K Buy
29,223
+7,100
+32% +$125K ﹤0.01% 1155
2024
Q1 		$346K Hold
22,123
– – ﹤0.01% 1331
2023
Q4 		$330K Sell
22,123
-12,523
-36% -$168K ﹤0.01% 1346
2023
Q3 		$560K Buy
34,646
+17,323
+100% +$499K ﹤0.01% 1001
2023
Q2 		$719K Buy
17,323
+1,800
+12% +$112K ﹤0.01% 881
2023
Q1 		$934K Hold
15,523
– – 0.01% 718
2022
Q4 		$1.14M Buy
15,523
+400
+3% +$30.1K 0.01% 618
2022
Q3 		$1.15M Hold
15,123
– – 0.01% 621
2022
Q2 		$1.05M Buy
15,123
+1,000
+7% +$75.3K 0.01% 671
2022
Q1 		$1.17M Sell
14,123
-2,000
-12% -$147K 0.01% 730
2021
Q4 		$1.21M Buy
+16,123
New +$1.62M 0.01% 798
2021
Q3 		– Sell
-15,723
Closed -$3.49M – 1689
2021
Q2 		$3.49M Buy
+15,723
New +$3.06M 0.02% 536
2021
Q1 		– Sell
-15,923
Closed -$2.75M – 1580
2020
Q4 		$2.75M Buy
+15,923
New +$2.18M 0.02% 541

Other funds holding NVCR

BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
CMF
Counterpoint Mutual Funds San Diego, California $1.01B AUM 37.65% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CG
Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return

Handelsbanken Fonder's NVCR Position: Q2 2026 in Review

Handelsbanken Fonder increased its NovoCure (NVCR) stake by 37% in Q2 2026, buying an estimated $210K and bringing the position to 51,223 shares worth $776K. The position accounts for ﹤0.01% of the portfolio, ranked #1240.

Handelsbanken Fonder first reported a position in NVCR in Q4 2020 and has held it in 21 quarters since. The position peaked at $3.49M in Q2 2021. 42 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Handelsbanken Fonder held 51,223 shares of NovoCure worth $776K as of Q2 2026.
  • Handelsbanken Fonder bought 13,900 NovoCure shares in Q2 2026, an estimated $210K.
  • NovoCure made up ﹤0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #1240 holding.
  • Handelsbanken Fonder first reported a position in NovoCure in Q4 2020 and has held it in 21 quarters since.
  • Handelsbanken Fonder's NovoCure position peaked at $3.49M in Q2 2021.
  • 42 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.